BiondVax Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch BVXV and buy or sell other stocks, ETFs, and their options commission-free!

About BVXV

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. 

CEO
Amir Reichman, MBA
CEOAmir Reichman, MBA
Employees
31
Employees31
Headquarters
Jerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded
2003
Founded2003
Employees
31
Employees31

BVXV Key Statistics

Market cap
1.16M
Market cap1.16M
Price-Earnings ratio
-0.06
Price-Earnings ratio-0.06
Dividend yield
Dividend yield
Average volume
17.03K
Average volume17.03K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.18
52 Week high$6.18
52 Week low
$0.613
52 Week low$0.613

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.